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Abstract
Objective: To evaluate the impact of changes to urine testing orderables in computerized physician order entry (CPOE) system on urine
culturing practices.
Design: Retrospective before-and-after study.
Setting: A 1,250-bed academic tertiary-care referral center.
Patients: Hospitalized adults who had ≥1 urine culture performed during their stay.
Intervention: The intervention (implemented in April 2017) consisted of notifications to providers, changes to order sets, and inclusion of the
new urine culture reflex tests in commonly used order sets.We compared the urine culture rates before the intervention (January 2015 to April
2016) and after the intervention (May 2016 to August 2017), adjusting for temporal trends.
Results: During the study period, 18,954 inpatients (median age, 62 years; 68.8% white and 52.3% female) had 24,569 urine cultures ordered.
Overall, 6,662 urine cultures (27%) were positive. The urine culturing rate decreased significantly in the postintervention period for any specimen
type (38.1 per 1,000 patient days preintervention vs 20.9 per 1,000 patient days postintervention; P< .001), clean catch (30.0 vs 18.7; P< .001) and
catheterized urine (7.8 vs 1.9; P < .001). Using an interrupted time series model, urine culture rates decreased for all specimen types (P < .05).
Conclusions: Our intervention of changes to order sets and inclusion of the new urine culture reflex tests resulted in a 45% reduction in the
urine cultures ordered. CPOE system format plays a vital role in reducing the burden of unnecessary urine cultures and should be implemented
in combination with other efforts.
(Received 21 September 2018; accepted 11 December 2018)
Urinalysis and urine culture are commonly ordered tests among
hospitalized patients suspected of urinary tract infection (UTI).
However, these tests are often ordered for patients without clinical
suspicion of UTI, leading to unnecessary testing and increased hos-
pital costs.1–3 Positive urine cultures are a major driver for antibiotic
treatment.4–11 Several studies have reported that the treatment of
asymptomatic bacteriuria (ASB) does not affect patient outcomes
and leads to unnecessary antibiotic use, increasing the prevalence
of antibiotic-resistant organisms and Clostridium difficile infec-
tion.12–14 Despite Infectious Disease Society of America and other
professional societies’ recommendations to avoid antibiotic prescrip-
tions for asymptomatic bacteriuria,14–17 its treatment is still common.
Previous interventions to prevent unnecessary urine testing
have included provider education, use of pocket cards, antimicro-
bial stewardship efforts, reflex urine culture cancellation and 2-step
urine culture ordering.6,7,12,13,18–22 However, data on the effect of
changes in electronic order sets and its role on inpatient urine test-
ing practices are limited.
In this study, we evaluated the impact of changes to the in-
patient urine orders in a computer physician order entry (CPOE)




This retrospective before-and-after study included patients admitted
to Barnes-Jewish Hospital (BJH), a 1,250-bed teaching hospital,
from January 1, 2015, to August 31, 2017, who had≥1 urine culture
ordered during their stay. Patients who were admitted during the
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study period but did not have a urine culture ordered during their
stay and patients who had their urine cultures obtained at an out-
patient settings or the emergency department (ED) were excluded.
Intervention
A staged intervention was performed to clarify test names and to
reduce the number of reflex urine cultures performed for nonspe-
cific indications (eg, isolated proteinuria) bymaking changes to the
urine reflex test panel at BJH (Table 1). This intervention was ini-
tiated in the CPOE system on January 28, 2016. E-mail notification
to providers with the new urine reflex tests was sent prior to ini-
tiation. The inclusion of the new reflex tests in commonly used
order sets within the CPOE system (eg, medical intensive care unit
admission orders) was completed on April 19, 2016; therefore,
April 2016 was used as the intervention month. January 2015
through April 2016 was the preintervention period and May
2016 through August 2017 was the postintervention period.
Data collection
Patient and laboratory data were abstracted from the hospital
medical informatics database. Data included patient demographics
(ie, age, race, and sex), laboratory test results (ie, urinalysis, micro-
scopic exam and urine culture), and discharge disposition (ie,
home, other facility, etc). For urine cultures with accompanying
urinalysis or microscopy, the time between the urine culture
and urinalysis and/or microscopy was calculated. Type of urine
culture specimen was also noted (ie, clean catch, catheterized,
or procedure related) as indicated by the ordering clinician.
For patients with multiple urine cultures during an admission,
each sample was treated as an independent observation.
Definitions
Urine cultures with growth of ≥100,000 colony-forming units
(CFU)/mL for a clean-catch specimen and ≥10,000 CFU/mL for
a catheterized specimen were considered positive results. Urine
cultures that were negative for significant growth or contaminated
were considered negative for this analysis. Leukocyte esterase ≥1
identified on urinalysis and >5 white blood cells per high-power
field on urine microscopy were treated as abnormal and positive test
results. We defined an isolated urine culture as a culture without an
associated urinalysis and/or urine microscopy performed within
1 calendar day before or after the culture was performed.
Catheter-associated urinary tract infection (CAUTI) surveillance
was independently conducted by the hospital infection prevention
department during the study period. A CAUTI was defined accord-
ing to National Healthcare Safety Network definitions23 as a UTI
where an indwelling urinary catheter was in place for >2 calendar
days on the date of event, with day of device placement being day 1,
and an indwelling urinary catheter was in place on the date of event
or the day before. If an indwelling urinary catheter was in place for
>2 calendar days and then removed, theUTI criteriamust have been
fully met on the day of discontinuation or the next day.
Cost assessment
Unit cost of a urine culture was obtained from theMedicare Clinical
Laboratory Fee Schedule using national median Medicare payment
Table 1. Urine Order Set Definitions During the Study Period
Preintervention (January 2015–April 2016) Postintervention (May 2016–August 2017)
Test Name(s) Definition Test name(s) Definition
UA Reflex to Microscopy
WITH Culture
If urinalysis is positive for nitrites OR leukocyte esterase,










Perform urine dipstick. If positive for any
protein >trace, blood, nitrite, or
leukocyte esterase, then proceed to
microscopy and culture.
UA Reflex for Neutropenic
Patients
If urinalysis is positive for protein (>trace), blood,
nitrites, OR leukocyte esterase, then microscopy





Perform urine dipstick. If positive
for any protein >trace, blood, nitrite,
or leukocyte esterase, then proceed to
microscopy.
UA Reflex to Microscopy
WITHOUT Culture
If urinalysis is positive for protein (>trace), blood,











Macroscopic dipstick urinalysis only
UA Microscopy
UA Microd
Urine sediment examination only UA Microscopy
UA Micro





Urine culture, X (X= aerobic,
fungal, mycobacterial)
Note. UA, urinalysis.
aUrine Flex and Urine Flex C/S were the same orders with different names during the preintervention period;
bUA Reflex and UA W/Reflexed were the same orders with different names during the preintervention period.
cUrine Macro, Urinalysis, UA Macro and UA Dip Macroscopic were the same orders with different names during the study period.
dUA Microscopy and UA Micro were the same orders with different names during the study period.
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rate of $15.00 per urine culture (not adjusted to inflation).24 Total
laboratory charges for urine cultures during the preintervention
and postintervention periods were calculated, and cost difference
was estimated.
Statistical analysis
Patient demographics and characteristics are reported on a per-
admission basis. Urine cultures rates are reported per 1,000 patient
days (ie, the total patient days for all patients admitted during the
study period). CAUTI rates are reported per 1,000 patient days and
catheter days. Demographic characteristics and urine culture data
were compared for the preintervention period and the postinter-
vention period using the Wilcoxon rank-sum test, χ2 test, or
univariable logistic regression where appropriate. An interrupted
time-series model was used to analyze the impact of the interven-
tion on urine culture rates during the study period. Data were
analyzed using SAS version 9.3 software (SAS Institute, Cary,
NC). The Washington University Human Research Protection
Office approved this study.
Results
Patient characteristics
During the study period, 18,954 patients had ≥1 urine culture
ordered during their hospital stay (11,780 during the preinterven-
tion vs 7,174 during the postintervention period) (Table 2). The
median age of the patients was 62 years; ~69% of patients were
white and 52.3% were female. Also, ~66% of these patients were
routinely discharged home and 25.5% were discharged to or
transferred to other facilities. Patients in the preintervention
period were slightly younger (61 years preintervention vs 62 years
postintervention; P = .015), were predominantly male (48.4% vs
Table 2. Characteristics of Patients With ≥1 Urine Cultures Obtained From Inpatients
Variable





No. (%)c P Value
Age, median (IQR) 62 (49–72) 61 (48–72) 62 (49–72) .015
Race
White 13,043 (68.8) 8,098 (68.7) 4,945 (68.9) Reference
Black 4,791 (25.3) 2,926 (24.8) 1,865 (26.0) .217
Other 1,120 (5.9) 756 (6.4) 364 (5.1) <.001
Sex
Male 9,040 (47.7) 5,702 (48.4) 3,338 (46.5) .012
Female 9,914 (52.3) 6,078 (51.6) 3,836 (53.5) Reference
Median urine culture per admission (range) 1 (1–12) 1 (1–12) 1 (1–12)
Discharge statusd
Discharged to home 12,336 (65.6) 7,762 (66.6) 4,574 (63.9) <.001
Discharged to other facility 4,805 (25.5) 2,890 (24.8) 1,915 (26.7) Reference
Other 1,670 (8.9) 999 (8.6) 671 (9.4) .815
Note. IQR, interquartile range.
aEach admission is treated as an observation for this analysis purpose. Study cohort includes patients admitted to hospital whose urine was tested (≥1) for culture at the hospital during the
study period (does not include urine cultures performed at the emergency department, a 24/7 clinic, or in any outpatient setting). Overall, 18,954 patient admissions contributed to 24,569 urine
culture tests during the study period (median, 1; IQR, 1–1).
bJanuary 2015 to April 2016.
cMay 2016 to August 2017.
dOverall: missing (n= 143); other: still in hospital (n= 9); died (n= 1,532); left against advice (n= 106); unknown (n= 23). Preintervention: missing (n = 129); still in hospital (n = 5); admitted to
hospital (n= 12); died (n= 910); left against advice (n = 72); Postintervention: missing (n= 14); still in hospital (n = 4); died (n = 622); left against advice (n= 34); unknown (n = 11).
Table 3. Comparison of Urine Culture Testing Practices Before and After the Intervention
Variable Total (n= 24,569) Preintervention (n= 15,746)a Postintervention (n= 8,823)b P Value
Positive cultures, No. (%)c 6,642 (27.0) 4,021 (25.5) 2,621 (29.7) <.001
Isolated cultures, No. (%)c 6,240 (25.4) 4,101 (26.0) 2,139 (24.2) .002
Urine cultures per 1,000 patient daysd 29.4 38.1 20.9 <.001
Catheterized urine cultures per 1,000 patient days 4.8 7.8 1.9 <.001
Catheter associated UTI, No. (%) 250 (1.0) 125 (0.8) 125 (1.4)
CAUTI per 1,000 patient days 0.30 0.30 0.30 .871
CAUTI per 1,000 catheter days 1.26 1.25 1.27 .899
Note: UTI, urinary tract infection; CAUTI, catheter associated urinary tract infection.
aJanuary 2015 to April 2016.
bMay 2016 to August 2017.
cSee methods for definitions.
dBased upon 413,137 patient days preintervention and 421,714 patient days postintervention for all patients admitted to the hospital during the study period (see Methods).
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46.5%; P = .012), and were routinely discharged home (66.6% vs
63.9%; P < .001) compared to the postintervention period.
Urine culture characteristics
A total of 24,569 urine cultures were ordered (during 18,954
admissions at the rate of 29.4 cultures per 1,000 patient days;
median, 1 urine culture per admission) during the study period.
Of these, 70.7% had an associated urinalysis and 70.4% had an
associated microscopy (25.4% of urine cultures were deemed to
be isolated). Overall, 6,642 urine cultures (27%) were positive.
The proportion of positive urine cultures increased in the postin-
tervention period (25.5% preintervention vs 29.7% postinterven-
tion; P < .001), whereas the proportion of isolated urine
cultures decreased (26.0% preintervention vs 24.2% postinterven-
tion; P= .002) (Table 3).
Urine culture rates by specimen type
Urine culture decreased by 45.1% in the postintervention period
(38.1 per 1,000 patient days preintervention vs 20.9 per 1,000
patient days postintervention; P < .001) (Table 3). This decrease
was observed for clean catch (30.0 per 1,000 patient days preinter-
vention vs 18.7 per 1,000 patient days postintervention; P < .001)
and catheterized urine cultures (7.8 per 1,000 patient days prein-
tervention vs 1.9 per 1,000 patient days postintervention; P< .001),
whereas procedure-related urine cultures remained stable at 0.3
per 1,000 patient days (Fig. 1).
When adjusted for impact of the intervention using an inter-
rupted time series model, urine culture rates decreased signifi-
cantly for overall (P < .001), catheterized (P < .001), and
isolated cultures (P= .027), respectively (Fig. 2).
Catheter associated urinary tract infections (CAUTI)
Overall, 250 CAUTIs were identified during the study period (0.30
per 1000 patient days); however, after the intervention there was no
significant change in the CAUTI rates (0.30 per 1,000 patient days
preintervention vs 0.30 per 1,000 patient days postintervention;
P= .871; 1.25 per 1,000 catheter days preintervention vs 1.27
per 1,000 catheter days postintervention; P= .899) (Table 3).
Effect of intervention on laboratory costs
Our intervention resulted in a $6,490 reduction in the mean
monthly laboratory cost during the postintervention period, with
an estimated total cost savings of $103,345 for inpatient urine cul-
ture laboratory costs in the postintervention period ($236,190 pre-
intervention vs $132,345 in the postintervention period).
Discussion
In this retrospective study, we observed a 45.1% unadjusted
decrease in the rate of inpatient urine cultures performed because
of changes to electronic orders in the computer physician order
entry system. The reduction in the urine culture rate was most
marked for the catheterized (75.6%) compared to a clean-catch
specimens (37.8%). We also noticed a 16.4% increase in the pro-
portion of positive urine cultures and a 6.9% decrease in the
proportion of isolated urine cultures obtained. Overall, our inter-
vention resulted in an estimated reduction of $103,845 in lab-
oratory charges to patients.
Unnecessary ordering of urine cultures and inappropriate anti-
microbial use for asymptomatic bacteriuria remain common
among clinicians.13,15–17,25–27 Lack of familiarity with the recom-
mendations, excessive testing in patients with comorbidities, and
certain practice patterns among physicians are some of the
common factors driving this clinical practice.9,28 Moreover, a urine
culture result is often difficult for clinicians to ignore and drives
antimicrobial therapy regardless of symptoms.29
Several prior efforts to prevent treatment of asymptomatic bac-
teriuria have included educational sessions,6,30 pocket cards with
diagnostic algorithms with audit and feedback for training clini-
cians,13 and antimicrobial stewardship efforts. Recently, Hartley
et al4 replicated these interventions in hospitalist-based service
in 3 different hospitals and observed a 24% reduction in ASB treat-
ment rates, resulting in fewer days of antimicrobial therapy. Other
recent interventions have included focus groups interviews for
identifying factors that affect nurse initiated urine culture ordering
and collection practices,31 reflex urine culture cancellation,21 and
2-step urine culture ordering in the emergency department.22
Although several of these upstream interventions are aimed toward
eliminating unnecessary ordering and downstream interventions
are aimed toward reducing treatment of asymptomatic bacteriuria,
knowledge on the role of CPOE in reducing the burden of unnec-
essary ordering in the inpatient setting is limited.
Because of our intervention, we also noticed a significant
increase in the proportion of urine cultures that were positive
during the postintervention period. This finding may indicate
increased clarity of reflex algorithm test names and a change in
the behavior of ordering clinicians (eg, urine cultures are more
likely to be ordered in patients with a higher pretest probability).
The postintervention period had a significantly higher proportion
of positive urine cultures with an associated abnormal or positive
urinalysis (1,896 of 2,621 [72.3%] vs 2,442 of 4,021 [60.7%];
P< .001) and a significantly lower proportion of positive urine cul-
ture results with an associated negative urinalysis (122 of 2,621
[4.7%] vs 479 of 4,021 [11.9%]; P < .001). These findings suggests
that a chance of an important UTI having been missed due to the
decreased rate of urine culture following the intervention was less
unlikely. Although we noticed a significant but small (6.9%)
decrease in the isolated urine culture and substantial decrease
Fig. 1. Urine culture rate by specimen type. *P value for clean-catch and catheterized
cultures. Note. The preintervention period was January 2015 to April 2016 and the
postintervention period was May 2016 to August 2017.
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(75.6%) in the rate of catheterized urine cultures per 1,000 patient
days, there was no significant change in the CAUTI rate postinter-
vention. Given that we previously reported that isolated urine cul-
tures were more likely to be ordered on catheterized patients and
patients with prolonged hospital stays,32 we evaluated the propor-
tion of CAUTIs associated with isolated urine cultures. We found
no significant difference between study periods in the proportion
of CAUTIs that were identified based on isolated urine cultures (39
of 125 [31.2%] preintervention vs 26 of 125 [20.8%] postinterven-
tion; P= .06). These findings suggest that for patients in whom
a clinical suspicion of CAUTI existed, clinicians were ordering
diagnostic tests and detecting it in both intervention periods.
Therefore, additional infection prevention efforts may be required
in this study cohort to prevent CAUTIs.
Our intervention resulted in an estimated cost savings of
~$104,000 for inpatient laboratory costs after implementation.
This represents a fraction of the total costs and does not reflect
the costs saved based on the medical decisions (eg, delayed hospital
discharge) and antimicrobial therapy.27 In an era of reducing reim-
bursement for clinical laboratory testing,33 the prudent use of
common diagnostic tests in patient care is increasingly important.
The limitations of our study include a retrospective design,
the absence of chart review for test indication, and lack of data
on antibiotic use for assessment of antimicrobial therapy. We were
unable to assess asymptomatic bacteriuria because data on clinical
symptoms or signs were not collected. In addition, this is a single
academic medical center and may not be generalizable to other
settings. Ourmedical informatics database does not include orders;
therefore, we were unable to directly evaluate the frequency of
urinalysis reflex to microscopy with culture and types of urine cul-
ture orders. We attempted to address this limitation by examining
urine cultures that were performed along with urinalysis and/or
microscopy, but we would not be able to identify how much our
intervention reduced the proportion of urinalysis that reflexed
to culture. The median number of urine cultures for the preinter-
vention and postintervention periods were the same (including
demographic characteristics patients who had >1 urine culture);
therefore, we did not make any adjustments for the repeat obser-
vations. We were unable to directly assess whether antibiotic use
changed in patients with urinary testing because of the interven-
tion, and its subsequent effect on antimicrobial resistance among
urinary pathogens. Strengths of our study include using data from
a large academic medical center and electronic order sets for the
intervention. The use of CPOE for such intervention requires
relatively little ongoing intervention effort compared with other
diagnostic stewardship efforts, which require constant monitoring.
Our study results complement a similar CPOE intervention con-
ducted in the emergency department of the same hospital, where
we observed a 47% decrease in urine cultures ordered when only
“urinalysis with reflex tomicroscopy”was retained in the frequently
ordered list of laboratory tests.34 A similar study of urine diagnostics
reported that the elimination of reflexed microscopy examination
for inpatient locations resulted in a 95% reduction in the urine
microscopy performed.35
In summary, a staged intervention to clarify test names and
inclusion of new reflex tests resulted in a 45% reduction in the urine
cultures ordered with an estimated cost savings of $104,000. Further
studies are needed to evaluate the role of CPOE in combination
with education sessions for ordering physicians and antimicrobial
stewardship efforts in reducing the incidence of unnecessary urine
cultures. Future research should also focus on reducing isolated
urine cultures and CAUTIs.
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